Can the Internet help to meet the challenges in ADME and e-ADME?
暂无分享,去创建一个
[1] A. Li,et al. Screening for human ADME/Tox drug properties in drug discovery. , 2001, Drug discovery today.
[2] S. Ekins,et al. Progress in predicting human ADME parameters in silico. , 2000, Journal of pharmacological and toxicological methods.
[3] J Devillers,et al. e-Statistics for deriving QSAR models , 2002, SAR and QSAR in environmental research.
[4] S. Ekins,et al. Present and future in vitro approaches for drug metabolism. , 2000, Journal of pharmacological and toxicological methods.
[5] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[6] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[7] Malcolm Rowland,et al. Physiologic modeling of cyclosporin kinetics in rat and man , 1991, Journal of Pharmacokinetics and Biopharmaceutics.
[8] R A Morrison,et al. Current methodologies used for evaluation of intestinal permeability and absorption. , 2000, Journal of pharmacological and toxicological methods.
[9] G Beck,et al. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. , 2001, Journal of pharmaceutical sciences.
[10] Lawrence X. Yu,et al. Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship , 2000, Pharmaceutical Research.
[11] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[12] A. Alex,et al. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. , 1999, Journal of medicinal chemistry.
[13] J. Topliss,et al. QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.
[14] A J M Carpy. WWW small molecule modeling , 2002, SAR and QSAR in environmental research.
[15] S. Anzali,et al. Discriminating between drugs and nondrugs by prediction of activity spectra for substances (PASS). , 2001, Journal of medicinal chemistry.
[16] D A Smith,et al. Pharmacokinetics and metabolism in early drug discovery. , 1999, Current opinion in chemical biology.
[17] S. Ekins,et al. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. , 2000, Drug metabolism and disposition: the biological fate of chemicals.
[18] H. Kubinyi,et al. A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.
[19] Han van de Waterbeemd,et al. Property-Based Design: Optimization of Drug Absorption and Pharmacokinetics , 2001 .
[20] Igor V. Tetko,et al. Internet Software for the Calculation of the Lipophilicity and Aqueous Solubility of Chemical Compounds , 2001, J. Chem. Inf. Comput. Sci..
[21] B. Walther,et al. Rapid assessment of drug metabolism in the drug discovery process. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[22] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[23] M. Feher,et al. A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.